PITTSBURGH (WHDH) - Mylan is recalling Epipens distributed in the United States due to a serious defect.
The company says the potential defect could “make the device difficult to activate in an emergency” and that it could have “significant health consequences for a patient experiencing a life-threatening allergic reaction.”
Two reported incidents were linked to a single lot, but the company says it’s expanding the recall to include additional lots as a precaution.
The recall impacts the 0.3 mg and 0.15 mg strengths of EpiPen Auto-Injector. None of the recalled lots include the authorized generic for EpiPen Auto-Injector.
View the impacted lots below:
(Copyright (c) 2017 Sunbeam Television. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)